Merck nears $6bn biotech deal to boost cancer drug pipeline

All NewsMarch 25, 2026

Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last year

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent